Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Other Working Capital Changes (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Other Working Capital Changes for 2 consecutive years, with -$703542.0 as the latest value for Q4 2023.

  • Quarterly Other Working Capital Changes fell 169.89% to -$703542.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$926217.0 through Dec 2023, down 2371.7% year-over-year, with the annual reading at -$333881.0 for FY2025, 122.11% down from the prior year.
  • Other Working Capital Changes hit -$703542.0 in Q4 2023 for Bluejay Diagnostics, down from -$30707.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.0 million in Q4 2022 to a low of -$703542.0 in Q4 2023.